405 Business Magazine published an article this month highlighting Cortado’s funding of Sensulin, a biopharmaceutical company that is developing a glucose-responsive insulin for Type 1 and Type 2 diabetes. 405 Business Magazine focuses on sharing stories on local events and community to allow for visionary business leaders and up-and-coming young professionals to stay connected and in tune with our exciting and ever-evolving business landscape.
Read the article here: https://405business.com/cortado-ventures-invests-in-locally-founded-sensulin/